Prostate-specific membrane antigen (PSMA), a transmembrane protein encoded by the gene FOLH1 [9,10], is a relatively novel target for molecular imaging and therapy in prostate cancer imaging [11,12]. This evidence concerns the gene FOLH1 and Familial prostate cancer.